GSK Takes Pay-As-You Go Approach In Aspen Branded Generics Deal
GlaxoSmithKline's licensing deal with South Africa-based branded generics drug maker Aspen is illustrative of the company's approach to acquisitions under new CEO Andrew Witty
GlaxoSmithKline's licensing deal with South Africa-based branded generics drug maker Aspen is illustrative of the company's approach to acquisitions under new CEO Andrew Witty